<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20140811018760N6</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-03-06</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Effect of biofeedback in chronic constipation</public_title>
      <acronym></acronym>
      <scientific_title>The comparison between the effects of biofeedback with pelvic floor muscle training and biofeedback alone on chronic constipation in adult females: a randomized controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-02-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>66</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/44221</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Adult women with chronic constipation, if appropriate, were randomly assigned in the two intervention and control groups using blocks of size 6 and 9 blocks with 1: 1 allocation ratio. For the allocation concealment, the type of intervention received is written on a piece of paper and placed inside the opaque envelopes and the back of the envelope will be numbered. The envelopes will be opened according to the entry of the participants and the type of group for each patient will be specified accordingly, Blinding description: This study will be single blinded. Because of exercise nature in one group , participants in this study cannot be blind in which group they are. So only  the investigator (data assessor) will be blind. The statistician will also be blind.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic constipation.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Individuals in this group will receive Visual Therapy with Enraf (632x Myomed) biofeedback device, two 30- minute sessions per week, for 3 months. Step 1, Patient education and awareness;The paradoxical state of sphincter voluntary contraction or inability to relax the anal muscles during excretion is explained to the patient. Pushing during excretion (like stool excretion): At this stage, superficial electrodes are placed on the abdominal muscles to determine how they are operated during excretion. Stage III; Pelvic floor relaxation technique: At this stage the patient is flanked and the rectal probe is placed by the therapist then the patient will be taught how to facilitate the rectal canal and the rectum using a biofeedback monitor. Last step; the patient is asked to relax the anal canal while exerting pressure on the abdomen (abdominal rectus muscle and diaphragm). In the first stage, the breathing technique must be corrected when attempting to defecate. Bearing down maneuvers are taught to the patient. Intervention 2: Intervention group 2: In this group, the biofeedback intervention will be performed as in the previous group and the graded supervised pelvic floor muscle exercises will be conducted  by physiotherapist for each patient. The patient will perform one session per week of exercise under the supervision of a physiotherapist and will be given progressive exercise weekly.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fariba Ghaderi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rehabilitation Faculty, Daneshgah avenue, Tabriz</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5167631444</zip>
        <telephone>+98 41 3334 5121</telephone>
        <email>ghaderif@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fariba Ghaderi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rehabilitation Faculty, Daneshgah avenue, Tabriz</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5167631444</zip>
        <telephone>+98 41 3334 5121</telephone>
        <email>ghaderif@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Symptoms of chronic constipation for 6 month
No drug use in intervention groups during last two weeks 
Age range of 18-54 years</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>54 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Presence of systemic diseases
Irritable bowel syndrome
Secondary constipation anatomical, endocrine, metabolic, neurological, surgical factors
Blood diseases or taking anticoagulants drug such as Heparin and Warfarin
Abdominal aneurysm
Pregnant and lactating women
Presence Pacemaker
Psychological and psychiatric disorders
Addiction and Alcohol abuse
Understanding problems</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K59.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Constipation</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Individuals in this group will receive Visual Therapy with Enraf (632x Myomed) biofeedback device, two 30- minute sessions per week, for 3 months. Step 1, Patient education and awareness;The paradoxical state of sphincter voluntary contraction or inability to relax the anal muscles during excretion is explained to the patient. Pushing during excretion (like stool excretion): At this stage, superficial electrodes are placed on the abdominal muscles to determine how they are operated during excretion. Stage III; Pelvic floor relaxation technique: At this stage the patient is flanked and the rectal probe is placed by the therapist then the patient will be taught how to facilitate the rectal canal and the rectum using a biofeedback monitor. Last step; the patient is asked to relax the anal canal while exerting pressure on the abdomen (abdominal rectus muscle and diaphragm). In the first stage, the breathing technique must be corrected when attempting to defecate. Bearing down maneuvers are taught to the patient.</i_keyword>
      <i_keyword>Intervention group 2: In this group, the biofeedback intervention will be performed as in the previous group and the graded supervised pelvic floor muscle exercises will be conducted  by physiotherapist for each patient. The patient will perform one session per week of exercise under the supervision of a physiotherapist and will be given progressive exercise weekly.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Constipation severity. Timepoint: Before intervention and at the end of the intervention. Method of measurement: Comprehensive constipation questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Evaluation of the intensity of anal sphincter muscle activity. Timepoint: Before intervention and at the end of the intervention. Method of measurement: The intensity of sphincter muscle activity will be measured using an electromyograph (EMG).</sec_outcome>
      <sec_outcome>Evaluation intensity of abdominal muscle activity. Timepoint: Before intervention and at the end of the intervention. Method of measurement: The intensity of abdominal muscles activity will be measured using an electromyograph (EMG).</sec_outcome>
      <sec_outcome>Evaluation anal resting pressure. Timepoint: Before intervention and at the end of the intervention. Method of measurement: The anal resting pressure will be measured using the anorectal manometery.</sec_outcome>
      <sec_outcome>Evaluation anal squeeze pressure. Timepoint: Before intervention and at the end of the intervention. Method of measurement: The anal squeeze pressure will be measured using the anorectal manometery.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-12-08</approval_date>
        <contact_name>Ethics committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Rehabilitation faculty, Daneshgah avenue, Tabriz Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
